Spots Global Cancer Trial Database for schwannoma
Every month we try and update this database with for schwannoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI | NCT03593577 | Vestibular Schw... | 18 Years - | University Hospital, Strasbourg, France | ||
Evolution of Cochleovestibular Schwannomas | NCT04417868 | Schwannoma | 18 Years - | University Hospital, Strasbourg, France | ||
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma | NCT02282917 | Vestibular Schw... Meningioma Acoustic Neurom... Neurofibromatos... | AR-42 | 18 Years - | Massachusetts Eye and Ear Infirmary | |
Establishing Prospective Mediastinal Tumor Database of PUMCH | NCT06421805 | Thymic Epitheli... Teratoma Thymic Cyst Retrosternal Go... Germ Cell Tumor Lymphoma Schwannoma | - | Peking Union Medical College Hospital | ||
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery | NCT06112509 | Vestibular Schw... Neurinoma, Acou... Acoustic Neurom... | Vestibular exam | 18 Years - 90 Years | Centre Hospitalier Universitaire de Besancon | |
Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma | NCT01951365 | Schwannoma Neurinoma | 20 Years - | Seoul National University Hospital | ||
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis | NCT04163419 | Schwannomatosis Pain | Tanezumab Placebo | 18 Years - | Massachusetts General Hospital | |
Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma | NCT02988726 | CNS Tumor | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma | NCT01083966 | Vestibular Schw... | Bevacizumab (Av... | 18 Years - | Northwell Health | |
Natural History Study of Patients With Neurofibromatosis Type 2 | NCT00598351 | Neurofibromatos... | 8 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
Hippocampal Radiation Exposure and Memory | NCT00603694 | Arteriovenous M... Schwannoma Trigeminal Neur... | 18 Years - | University Health Network, Toronto | ||
Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma | NCT01951365 | Schwannoma Neurinoma | 20 Years - | Seoul National University Hospital | ||
Analysis of NF2 Mutations in Radiation-Related Neural Tumors | NCT00340496 | Neural Tumors | - | National Institutes of Health Clinical Center (CC) | ||
Evolution of Cochleovestibular Schwannomas | NCT04417868 | Schwannoma | 18 Years - | University Hospital, Strasbourg, France | ||
Evaluation of the CONVIVO System | NCT05139277 | Glioblastoma Glial Tumor Brain Metastase... Meningioma Schwannoma Pituitary Tumor | CONVIVO system Conventional hi... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients | NCT05576103 | Primary Brain T... Glioma Meningioma Schwannoma | 18 Years - 99 Years | University of California, San Diego | ||
SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) | NCT05254197 | Brain Tumor, Pr... Meningioma Schwannoma Pituitary Adeno... Gliomas Benign | 18 Years - | Seoul National University Hospital |